-
Something wrong with this record ?
Receptor partial agonism and method to express receptor partial activation with respect to novel Full Logistic Model of mixture toxicology
M. Ezechiáš, T. Cajthaml,
Language English Country Ireland
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Models, Biological * MeSH
- Drug Interactions * MeSH
- Logistic Models * MeSH
- Receptors, Cell Surface metabolism MeSH
- Dose-Response Relationship, Drug MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Living organisms interact with various chemical compounds via receptors, which is described by the receptor theory. The affinity of the biologically active compounds toward receptors and their ability to trigger a biological or toxic signal vary substantially. In this work, we describe a new insight into understanding of the mode of action of receptor partial agonists and the receptor theory using a Full Logistic Model (FLM) of mixture toxicology. We describe the hypothesis that the effect of a partial agonist can be mathematically described via separation of agonistic and antagonistic behavior of the partial agonist where the antagonistic effect is described as an action of the compound producing zero effect. In this way, a competitive antagonist can be considered as an agonist with zero effect. This idea is also placed into a context with classical concepts, e.g., Gaddum's equation. Using the assumption that competitive antagonists are agonists with no effect, equations describing the microscopic and macroscopic equilibrium constants have been derived. Accordingly, we show that the constants could be calculated from the measured partial agonistic dose-response curve. As a consequence, we provide a simple mathematical tool for comparison of dose-response curves of drugs according to their affinities and efficacies.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016253
- 003
- CZ-PrNML
- 005
- 20180523104241.0
- 007
- ta
- 008
- 180515s2018 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tox.2017.10.012 $2 doi
- 035 __
- $a (PubMed)29079363
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Ezechiáš, Martin $u Laboratory of Environmental Biotechnology, Institute of Microbiology of the CAS, v.v.i., Vídeňská 1083, Prague, 142 20, Czech Republic; Institute for Environmental Studies, Faculty of Science, Charles University in Prague, Albertov 6, Prague, 128 43, Czech Republic.
- 245 10
- $a Receptor partial agonism and method to express receptor partial activation with respect to novel Full Logistic Model of mixture toxicology / $c M. Ezechiáš, T. Cajthaml,
- 520 9_
- $a Living organisms interact with various chemical compounds via receptors, which is described by the receptor theory. The affinity of the biologically active compounds toward receptors and their ability to trigger a biological or toxic signal vary substantially. In this work, we describe a new insight into understanding of the mode of action of receptor partial agonists and the receptor theory using a Full Logistic Model (FLM) of mixture toxicology. We describe the hypothesis that the effect of a partial agonist can be mathematically described via separation of agonistic and antagonistic behavior of the partial agonist where the antagonistic effect is described as an action of the compound producing zero effect. In this way, a competitive antagonist can be considered as an agonist with zero effect. This idea is also placed into a context with classical concepts, e.g., Gaddum's equation. Using the assumption that competitive antagonists are agonists with no effect, equations describing the microscopic and macroscopic equilibrium constants have been derived. Accordingly, we show that the constants could be calculated from the measured partial agonistic dose-response curve. As a consequence, we provide a simple mathematical tool for comparison of dose-response curves of drugs according to their affinities and efficacies.
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 12
- $a lékové interakce $7 D004347
- 650 12
- $a logistické modely $7 D016015
- 650 12
- $a biologické modely $7 D008954
- 650 _2
- $a receptory buněčného povrchu $x metabolismus $7 D011956
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Cajthaml, Tomáš $u Laboratory of Environmental Biotechnology, Institute of Microbiology of the CAS, v.v.i., Vídeňská 1083, Prague, 142 20, Czech Republic; Institute for Environmental Studies, Faculty of Science, Charles University in Prague, Albertov 6, Prague, 128 43, Czech Republic. Electronic address: cajthaml@biomed.cas.cz.
- 773 0_
- $w MED00004533 $t Toxicology $x 1879-3185 $g Roč. 393, č. - (2018), s. 26-33
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29079363 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180523104425 $b ABA008
- 999 __
- $a ok $b bmc $g 1299877 $s 1013093
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 393 $c - $d 26-33 $e 20171025 $i 1879-3185 $m Toxicology $n Toxicology $x MED00004533
- LZP __
- $a Pubmed-20180515